Related Experiment Video

Updated: Jul 16, 2026

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
14:56

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies

Published on: May 6, 2022

Genetic manipulations of PPARs: effects on obesity and metabolic disease

Yaacov Barak1, Suyeon Kim

  • 1The Jackson Laboratory, ME, USA.

PPAR Research
|March 29, 2007
PubMed

Insights

Genetic manipulation of Peroxisome proliferator-activated receptors (PPARs) using gene knockout (KO) in mice is crucial for understanding their role in obesity and metabolic diseases. Research reveals valuable insights but highlights the need for further investigation into PPAR functions.

Area of Science:

  • Metabolic research
  • Genetics
  • Pharmacology

Background:

  • Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors activated by ligands with clinical benefits.
  • PPARs influence systemic physiology, including obesity, lipid metabolism, insulin resistance, and diabetes.
  • Understanding PPARs is key to addressing the obesity epidemic.

Purpose of the Study:

  • To review the lessons learned from over a decade of genetic PPAR modifications in mice.
  • To explore the functions of PPARs in vivo, particularly concerning obesity and metabolic pathways.
  • To identify future research directions for PPARs.

Main Methods:

  • Utilizing gene knockout (KO) mouse models to study PPAR functions in vivo.
  • Analyzing the effects of genetic PPAR modifications on metabolic regulation.
  • Reviewing existing literature on PPARs and their role in metabolic diseases.

Main Results:

  • Genetic modifications of PPARs have provided valuable insights into their regulatory roles.
  • PPARs significantly impact gene expression and fundamental metabolic pathways.
  • Despite progress, many questions regarding PPAR functions remain unanswered.

Conclusions:

  • PPARs are critical regulators of metabolism and play a significant role in obesity and related diseases.
  • Gene knockout studies in mice are essential for dissecting PPAR functions.
  • Further research is needed to fully elucidate the therapeutic potential of targeting PPARs.

More Related Videos

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System09:52

Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System

Published on: January 6, 2023

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...